Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Added: 1 week ago Source:  CFR Journal
Consumer wearable devices may offer a scalable method for the daily monitoring of heart failure (HF) symptoms and predicting exacerbations. A new study has detailed how a deep learning model using Apple Watch data can estimate cardiopulmonary fitness and provide early risk discrimination for unplanned healthcare events in patients with HF.¹MethodologyThe Ted Rogers Understanding Exacerbations of… View more
Author(s): Michael Kiernan Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure… View more
Author(s): Anjay Rastogi , Shelley Zieroth Added: 1 year ago
In this peer-to-peer discussion, Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Shelley Zieroth (University of Manitoba, CA) summarise and distil emerging real-world data on modern practices and approaches to treating hyperkalaemia during RAASi therapy in cardiorenal patients to optimise RAASI therapy.Download the Free Infographic View more
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more
Added: 2 years ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryTwo late-breaking clinical trials addressing cardiovascular outcomes in patients with diabetes were presented this week at the American College of Cardiology meeting in Atlanta, USA. One of these trials looked at the effects of the hyperactivation of the polyol pathway on diabetic cardiomyopathy (DbCM) and the other the effects of chelation therapy in patients with diabetes… View more
Author(s): Olli Arjamaa Added: 2 weeks ago
Research Area(s) / Expertise:

Coronary Interventions

Coronary Physiology

Job title: Professor, Interventional Cardiology, National University of Ireland, Galway, Ireland
At present, Professor William Wijns holds the esteemed position of SFI (Science Foundation Ireland) Professor in Interventional Cardiology at the Lambe Institute for Translational Medicine, Curam, and Saolta University Healthcare Group, National University of Ireland Galway. Additionally, he serves as the Director of the Smart Sensors Lab. Throughout his career, he has played various roles within… View more
Job title: Head of the School of Electrical and Mechanical Engineering